Vanderbilt Team to Study Virus Medication’s Ability to Prevent Lung Tissue Scarring
News
Researchers at Vanderbilt University Medical Center plan a Phase 1 clinical trial to evaluate the virus medication Valcyte’s ability to prevent lung tissue scarring in idiopathic pulmonary fibrosis patients. The trial ... Read more